TRDA
Entrada Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$6.67-3.12%
Price as of Jul 20, 2026
TRDA ownership
Entrada Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
4/100
Buys (3m)
1
Sells (3m)
2
Net (3m)
-$599.4K
Insiders buyingFirst buy in 2 quarters
Insider trades by month Buys Sells
Jun
Jul
Nov
Mar
Apr
May
Context3-month price -49.2%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | Chapman Ginadirector | Grant | 19,000 | $5.97 |
| Jun 12, 2026 | Thistle Marydirector | Grant | 19,000 | $5.97 |
| Jun 12, 2026 | PARMAR KUSHdirector, 10 percent owner: | Grant | 19,000 | $5.97 |
| Jun 12, 2026 | Radhakrishnan Mahadirector | Grant | 19,000 | $5.97 |
| Jun 12, 2026 | KIM PETER Sdirector | Grant | 19,000 | $5.97 |
| Jun 12, 2026 | Zeiher Bernhardt Gdirector | Grant | 19,000 | $5.97 |
| May 21, 2026 | Zeiher Bernhardt Gdirector | Buy | 5,000 | $5.86 |
| May 4, 2026 | Sethuraman Natarajanofficer: President, Research & Develop. | Sell | 25,907 | $15.39 |
| May 4, 2026 | Dowden Nathan Jofficer: President & COO | Sell | 15,000 | $15.33 |
| May 4, 2026 | Dowden Nathan Jofficer: President & COO | Option | 15,000 | $1.74 |
| Apr 2, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Sell | 2,500 | $12.95 |
| Mar 11, 2026 | Dowden Nathan Jofficer: President & COO | Sell | 11,894 | $13.05 |
| Mar 11, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Sell | 11,388 | $13.02 |
| Mar 11, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Sell | 5,089 | $13.00 |
| Mar 11, 2026 | Dowden Nathan Jofficer: President & COO | Sell | 3,116 | $13.02 |
| Mar 6, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Sell | 7,988 | $12.25 |
| Mar 3, 2026 | Doshi Dipaldirector, officer: CEO | Tax | 19,181 | $11.76 |
| Mar 3, 2026 | Sethuraman Natarajanofficer: President, Research & Develop. | Grant | 83,200 | $11.93 |
| Mar 3, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Grant | 44,600 | — |
| Mar 3, 2026 | Sethuraman Natarajanofficer: President, Research & Develop. | Tax | 3,898 | $11.66 |
| Mar 3, 2026 | Sethuraman Natarajanofficer: President, Research & Develop. | Grant | 55,800 | — |
| Mar 3, 2026 | Dowden Nathan Jofficer: President & COO | Grant | 55,800 | — |
| Mar 3, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Tax | 5,712 | $11.76 |
| Mar 3, 2026 | Doshi Dipaldirector, officer: CEO | Grant | 208,000 | $11.93 |
| Mar 3, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Grant | 66,600 | $11.93 |
| Mar 3, 2026 | Doshi Dipaldirector, officer: CEO | Tax | 9,869 | $11.66 |
| Mar 3, 2026 | Dowden Nathan Jofficer: President & COO | Tax | 14,038 | $11.76 |
| Mar 3, 2026 | Dowden Nathan Jofficer: President & COO | Tax | 7,223 | $11.66 |
| Mar 3, 2026 | Doshi Dipaldirector, officer: CEO | Grant | 139,400 | — |
| Mar 3, 2026 | WENTWORTH KORY JAMESofficer: Chief Financial Officer | Tax | 2,939 | $11.66 |
Source: TRDA SEC Form 4 filings, latest Jun 12, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their TRDA positions over the last 6 months (SEC Form 13F).
Increased
85
New positions
35
Reduced
76
Sold out
32
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 5.1M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 5.1M | Feb 17, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | May 15, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Reduced | 4.1M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 2.4M | May 13, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Increased | 2.3M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2.1M | Feb 12, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Increased | 2.1M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 1.6M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.3M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 1.0M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1.0M | May 15, 2026 |
| STEPSTONE GROUP LP | Unchanged | 761K | Feb 17, 2026 |
| STEPSTONE GROUP LP | Unchanged | 761K | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 667K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.